Citizens National Bank Trust Department’s Regeneron Pharmaceuticals REGN Stock Holding History

Citizens National Bank Trust Department’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-8	Closed	-$5.07K	–	395
2025 Q1	$5.07K	Hold	8	–	–	﹤0.01%	377
2024 Q4	$5.7K	Hold	8	–	–	﹤0.01%	324
2024 Q3	$8.41K	Hold	8	–	–	﹤0.01%	309
2024 Q2	$8.41K	Hold	8	–	–	﹤0.01%	309
2024 Q1	$7.7K	Hold	8	–	–	﹤0.01%	302
2023 Q4	$7.03K	Hold	8	–	–	﹤0.01%	284
2023 Q3	$6.58K	Hold	8	–	–	﹤0.01%	289
2023 Q2	$5.75K	Hold	8	–	–	﹤0.01%	299
2023 Q1	$6.57K	Hold	8	–	–	﹤0.01%	283
2022 Q4	$6K	Hold	8	–	–	﹤0.01%	285
2022 Q3	$6K	Hold	8	–	–	﹤0.01%	294
2022 Q2	$5K	Hold	8	–	–	﹤0.01%	303
2022 Q1	$5K	Hold	8	–	–	﹤0.01%	281
2021 Q4	$5K	Buy	+8	New	+$4.92K	﹤0.01%	282

Other funds holding REGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Citizens National Bank Trust Department's REGN Position: Q2 2025 in Review

Citizens National Bank Trust Department sold out of Regeneron Pharmaceuticals (REGN) in Q2 2025, closing a stake of 8 shares — an estimated $5.07K sold.

Citizens National Bank Trust Department first reported a position in REGN in Q4 2021 and held it in 14 quarters. The position peaked at $8.41K in Q3 2024. 1,203 funds tracked by Wall St. Rank hold REGN as of Q2 2025.

Citizens National Bank Trust Department reported no remaining Regeneron Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
Citizens National Bank Trust Department sold 8 Regeneron Pharmaceuticals shares in Q2 2025, an estimated $5.07K.
Citizens National Bank Trust Department first reported a position in Regeneron Pharmaceuticals in Q4 2021 and held it in 14 quarters.
Citizens National Bank Trust Department's Regeneron Pharmaceuticals position peaked at $8.41K in Q3 2024.
1,203 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2025.

Based on Citizens National Bank Trust Department's 13F filing for Q2 2025, filed 23 Jul 2025.